MedTrace Logo

MEDTRUM A7+ TouchCare Insulin Patch Pump (MedInPS)

NCT04223973 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2024-08-16

Study results available
· View outcomes & findings →

Summary

Demonstration study of the interest of the MEDTRUM A7+ TouchCare insulin patch pump versus INSULET Omnipod® patch pump

Conditions

Interventions

DEVICE

Medtrum A7+ insulin Pump

Use of the Medtrum pump during 3 months in combination with a CGM (Continuous Glucose Measurement)

BIOLOGICAL

Lab A1C

Measure of Lab A1C at baseline and end of study

Sponsors & Collaborators

  • Medtrum France

    lead INDUSTRY

Principal Investigators

  • Freddy PENFORNIS · Centre Hospitalier Francilien, Corbeil

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-29
Primary Completion
2021-03-01
Completion
2021-06-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04223973 on ClinicalTrials.gov